Accuray Incorporated (ARAY)

Currency in USD
1.520
-0.040(-2.56%)
Closed·
1.5200.000(0.00%)
·
ARAY Scorecard
Full Analysis
High shareholder yield
ARAY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.5201.560
52 wk Range
1.1402.950
Key Statistics
Prev. Close
1.56
Open
1.56
Day's Range
1.52-1.56
52 wk Range
1.14-2.95
Volume
556.19K
Average Volume (3m)
908.91K
1-Year Change
-30.28%
Book Value / Share
0.79
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ARAY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.500
Upside
+261.84%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period

Accuray Incorporated News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Accuray Incorporated Company Profile

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Accuray Incorporated Earnings Call Summary for Q4/2025

  • Q4 revenue of $128M exceeded forecasts by 3.01%, with EPS matching expectations at $0.01; stock rose 1.35% in aftermarket trading
  • International markets contributed 80% to total revenue; APAC revenue grew 200% YoY, offsetting challenges in US and Japan
  • FY2026 guidance: revenue $471-485M, adjusted EBITDA $31-35M; revenue split 45% H1, 55% H2; EBITDA weighted towards latter half
  • New product launches in China and emerging markets; Helix expansion in India, Bangladesh, Morocco, and Latin America as key growth driver
  • Risks include supply chain disruptions, market saturation in developed regions, tariff impacts, currency fluctuations, and competitive pressures
Last Updated: 13/08/2025, 22:18
Read Full Transcript

Compare ARAY to Peers and Sector

Metrics to compare
ARAY
Peers
Sector
Relationship
P/E Ratio
−107.6x−3.2x−0.5x
PEG Ratio
−1.19−0.100.00
Price/Book
2.1x3.2x2.6x
Price / LTM Sales
0.4x2.0x3.2x
Upside (Analyst Target)
228.9%36.3%38.8%
Fair Value Upside
Unlock6.0%5.4%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 5.500
(+261.84% Upside)

Earnings

Latest Release
Aug 13, 2025
EPS / Forecast
0.01 / 0.01
Revenue / Forecast
127.50M / 123.78M
EPS Revisions
Last 90 days

ARAY Income Statement

People Also Watch

52.94
BE
-3.39%
14.350
KFS
-0.83%
61.11
DBD
-2.07%
10.560
MFIN
-0.09%
188.53
COOP
+0.13%

FAQ

What Stock Exchange Does Accuray Trade On?

Accuray is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Accuray?

The stock symbol for Accuray is "ARAY."

What Is the Accuray Market Cap?

As of today, Accuray market cap is 171.27M.

What Is Accuray's Earnings Per Share (TTM)?

The Accuray EPS (TTM) is -0.02.

When Is the Next Accuray Earnings Date?

Accuray will release its next earnings report on 28 Oct 2025.

From a Technical Analysis Perspective, Is ARAY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Accuray Stock Split?

Accuray has split 0 times.

How Many Employees Does Accuray Have?

Accuray has 990 employees.

What is the current trading status of Accuray (ARAY)?

As of 31 Aug 2025, Accuray (ARAY) is trading at a price of 1.520, with a previous close of 1.56. The stock has fluctuated within a day range of 1.520 to 1.560, while its 52-week range spans from 1.140 to 2.950.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.